EPO Patents = 2

Trademarks = 2

Forward Citations = 2

Loading Chart...

4 inventors (with patents filed for the assignee):

Joshua R Shockey (3 out of 8 patents)

D Christopher Schelling (3 out of 3 patents)

Leah Elizabeth Appel (3 out of 16 patents)

4. John Klopp (2 out of 2 patents)

5. Boris Tchernychev (2 patents)

6. Leah E Appel (1 patent)

7. Richard J Looby (15 patents)

5 patents: Sort by Forward Citations

1. 12528805 - Solid forms of emetine (2026-01-20),

2. 11884663 - Solid forms of emetine (2024-01-30),

3. 11433041 - Palatable compositions including sodium phenylbutyrate and uses thereof (2022-09-06),

4. 11202767 - Methods of treating urea cycle disorders and maple syrup urine disease (2021-12-21),

5. 11154521 - Palatable compositions including sodium phenylbutyrate and uses thereof (2021-10-26),

Company Overview

Acer Therapeutics Inc. is a pharmaceutical company dedicated to the development and commercialization of therapies for patients with rare diseases. Their focus is on delivering innovative treatments that address unmet medical needs in rare diseases, such as vascular Ehlers-Danlos Syndrome and Maple Syrup Urine Disease. With a commitment to improving patient outcomes, Acer Therapeutics is at the forefront of advancing precision medicine for rare diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#61 in Newton, MA

#2,892 in Massachusetts

#51,570 in US

Newton, MA, United States of America

Acer Therapeutics Inc.

Forward Citations = 2

4 inventors:

Joshua R Shockey (3 out of 8 patents)

D Christopher Schelling (3 out of 3 patents)

Leah Elizabeth Appel (3 out of 16 patents)

4. John Klopp (2 out of 2 patents)

5. Boris Tchernychev (2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Acer Therapeutics Inc.. Retrieved from https://idiyas.com/company/acer-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]